OCULAR THERAPEUTICS RATIONALLY DESIGNED
Eleven Biotherapeutics designs and develops novel therapeutics for ocular diseases using its AMP-Rx™ protein engineering platform.
We create a new breed of potent and selective ophthalmic proteins.
Eleven is creating a pipeline of engineered protein drugs for ocular diseases that are rationally designed for improved biological and drug-like properties.
- Our differentiated ophthalmic protein products are designed for therapeutic impact in the ocular space. Eleven has a proprietary pipeline of product candidates for the treatment of ocular disease. Our products are engineered to treat both front-of-the-eye and back-of-the-eye diseases in new and effective ways.
LEARN MORE >
- Our technology enables innovative protein therapeutics. Eleven's proprietary protein engineering technology opens the potential to modulate key molecular targets responsible for the initiation or maintenance of an ocular disease.